China Biotech Services Holdings Limited (HKG:8037)

HKG:8037 Revenue

In the year 2025, China Biotech Services Holdings had annual revenue of 73.50M HKD with 4.25% growth. China Biotech Services Holdings had revenue of 38.87M in the half year ending June 30, 2025, a decrease of -78.68%.

• Revenue: 73.50M
• Revenue Growth: +4.25%
• P/S Ratio: 10.22
• Revenue / Employee: 552.65K
• Employees: 133
• Market Cap: 751.31M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	73.50M	2.99M	4.25%
Dec 31, 2024	70.51M	-141.48M	-66.74%
Dec 31, 2023	211.99M	-1.64B	-88.55%
Dec 31, 2022	1.85B	1.23B	196.83%
Dec 31, 2021	623.76M	-32.03M	-4.88%